Patents by Inventor Dennis J. McNamara

Dennis J. McNamara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pathogen Detection And Display System
    Publication number: 20240127943
    Abstract: A pathogen detection and display system is configured to discover and display the location of substances of interest, particularly pathogens that can spread infection. The detection and display system can be used in healthcare facilities on surfaces, medical equipment and devices, patients, and staff, for example.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 18, 2024
    Applicant: Cardeya Corporation
    Inventors: Charles R. Sperry, Lawrence J. Pillote, Vincent A. Piucci, Dennis F. McNamara, JR., James M. Wilson, III, Lisa Ruth Stowe, Brett M. Sitzlar, Barbara A. Piucci, David C. Chase
  • Antibacterial Agents
    Publication number: 20090275536
    Abstract: Described herein are antibacterial compounds, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections utilizing the compounds and pharmaceutical composition.
    Type: Application
    Filed: July 15, 2009
    Publication date: November 5, 2009
    Inventors: Timothy A. Johnson, Dennis J. McNamara, Debra A. Sherry, Peter Laurence Toogood
  • Antibacterial agents
    Patent number: 7557100
    Abstract: Described herein are antibacterial compounds, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections utilizing the compounds and pharmaceutical composition.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: July 7, 2009
    Assignee: Pfizer Inc.
    Inventors: Timothy A. Johnson, Dennis J. McNamara, Debra A. Sherry, Peter Laurence Toogood
  • Histidine-(N-benzyl glycinamide) inhibitors of protein farnesyl transferase
    Patent number: 6300501
    Abstract: Inhibitors of protein farnesyl transferase enzymes are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating cancer, restenosis, psoriasis, endometriosis, atherosclerosis, or viral infections.
    Type: Grant
    Filed: November 2, 1998
    Date of Patent: October 9, 2001
    Assignee: Warner-Lambert Company
    Inventors: Ellen M. Dobrusin, Annette M. Doherty, James S. Kaltenbronn, Daniele M. Leonard, Dennis J. McNamara, Judith Sebolt-Leopold, Kevon R. Shuler
  • Cycloalkyl inhibitors of protein farnesyltransferase
    Patent number: 6281194
    Abstract: Novel inhibitors of protein farnesyltransferase enzymes are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in controlling tissue proliferative diseases, including cancer, restenosis, atherosclerosis, psoriasis and endometriosis.
    Type: Grant
    Filed: June 2, 1999
    Date of Patent: August 28, 2001
    Assignee: Warner-Lambert Company
    Inventors: Annette M. Doherty, James S. Kaltenbronn, Daniele M. Leonard, Dennis J. McNamara
  • Deoxyadenosine compounds and methods of making and using the same
    Patent number: 4908441
    Abstract: 3'-Acyl-2-chloro-2'-deoxy-5'-adenylic acids (I) as well as a method for their production, pharmaceutical compositions comprising the compounds, and methods of treatment using the compound in dosage forms. The compounds of the invention have pharmacological properties and are useful antimicrobial agents and antitumor agents.
    Type: Grant
    Filed: July 19, 1988
    Date of Patent: March 13, 1990
    Assignee: Warner-Lambert Company
    Inventors: Phillip D. Cook, Dennis J. McNamara
  • Substituted quinazolinones as anticancer agents
    Patent number: 4857530
    Abstract: Novel 6-substituted-4(3H)-quinazolinones are described as well as methods for the preparation and pharmaceutical composition of same, which inhabit the enzyme thymidylate synthase (TS) and are thus useful as anticancer agents.
    Type: Grant
    Filed: November 3, 1987
    Date of Patent: August 15, 1989
    Assignee: Warner-Lambert Company
    Inventors: Ellen M. Berman, Leslie M. Werbel, Dennis J. McNamara
  • Methods of using 2-chloro-2'-deoxyadenosine-5'-phosphate and its salts
    Patent number: 4826823
    Abstract: Nucleotide compounds are provided, namely 2-chloro-2'-deoxyadenosine 5'-phosphate compounds (I) especially as the monosodium and disodium salt, as well as a method for their production, pharmaceutical compositions comprising the compounds, and methods of treatment using the compounds in dosage form. The compounds of the invention have pharmacological properties and are useful antimicrobial agents, antiviral agents, and antileukemic agents.
    Type: Grant
    Filed: December 31, 1985
    Date of Patent: May 2, 1989
    Assignee: Warner-Lambert Company
    Inventors: Phillip D. Cook, Roland K. Robins, Dennis J. McNamara
  • Compound 2-iodo-2'-deoxyadenosine
    Patent number: 4719295
    Abstract: Nucleotide and nucleoside compounds are provided, namely 2-halo-2'-deoxyadenosine 5'-phosphate compounds (I) especially as the monosodium and disodium salt, and 2-iodo-2'-deoxyadenosine (II); as well as a method for their production, pharmaceutical compositions comprising the compounds, and methods of treatment using the compounds in dosage form. The compounds of the invention have pharmacological properties and are useful antimicrobial agents, antiviral agents, and antileukemic agents.
    Type: Grant
    Filed: June 27, 1986
    Date of Patent: January 12, 1988
    Assignee: Warner-Lambert Company
    Inventors: Phillip D. Cook, Roland K. Robins, Dennis J. McNamara
  • 4-amino-3-halo-2-pyridinone nucleoside and nucleotide compounds
    Patent number: 4681873
    Abstract: 4-Amino-3-halo-1-.beta.-D-ribofuranosyl-2-(1H)-pyridinone, 4-amino-3-halo-1-(2-deoxy-.beta.-D-pentofuranosyl)-2(1H)-pyridinone, and nucleosides and 4-amino-3-halo-1-(2-deoxy-2,2-difluoro.beta.-D-pentofuranosyl)-2(1H)-pyrid inone nucleosides and nucleotides are useful as antiviral agents and possess in vivo activity against the L1210 murine leukemia cell line.
    Type: Grant
    Filed: July 29, 1985
    Date of Patent: July 21, 1987
    Assignee: Warner-Lambert Company
    Inventors: Dennis J. McNamara, Phillip D. Cook
  • Process for preparing 2-.beta.-D-ribofuranosylselenazole-4-carboxamide
    Patent number: 4619996
    Abstract: A chemical process for preparing 2-.beta.-D-ribofuranosylselenazole-4-carboxamide, comprises reacting 2,3,5-tri-O-benzoyl-.beta.-D-ribofuranosyl-1-carbonitrile with gaseous hydrogen selenide in a polar organic solvent.
    Type: Grant
    Filed: July 9, 1984
    Date of Patent: October 28, 1986
    Assignee: Warner-Lambert Company
    Inventors: P. Dan Cook, Dennis J. McNamara
  • Process for producing 4-carbamoyl-1H-imidazolium-5-olate
    Patent number: 4503235
    Abstract: A process is provided for producing 4-carbamoyl-1H-imidazolium-5-olate (I) ##STR1## by reacting aminomalonamide H.sub.2 N--CH(CONH.sub.2).sub.2 and formamidine CH(.dbd.NH)NH.sub.2 compound in a liquid medium comprising alcohol under conditions such that the product I can be obtained in a solid form that is directly recoverable from the medium, free of aminomalonamide and recrystallizable.
    Type: Grant
    Filed: March 11, 1983
    Date of Patent: March 5, 1985
    Assignee: Warner-Lambert Company
    Inventors: Phillip D. Cook, Dennis J. McNamara